Vyant Bio, a New Jersey-based biotech firm, uses human-derived organoid models and machine learning to identify drugs for complex neurodevelopmental and neurodegenerative conditions. Its focus is on discovering innovative and repurposed clinical small molecules for genetic disorders such as Rett Syndrome, CDKL5 deficiency, and Parkinson's disease. Vyant Bio collaborates with other companies to find treatments for Parkinson's Disease.